A new strategic phase for genomic medicine in UK health services.
In June 2009, the Science and Technology Committee of the UK House of Lords published a report on genomic medicine, based on expert evidence collected over an 18-month period. Crucially, the report signaled that the use of genomic medicine was at a crossroads, due to the rapid development of new technologies, and opened up opportunities across the whole of medicine and healthcare. This commentary responds to the report's call for a new health service strategy, including a new genetics White Paper from the Government, and suggests some of the important elements that need further consideration.
Burton
Hilary
H
PHG Foundation, 2 Worts Causeway, Cambridge, CB1 8RN, UK. hilary.burton@phgfoundation.org.
Wright
Caroline F
CF
Zimmern
Ron
R